[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-354128-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-354128-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","postpartum-breast-cancer-evidence-for-a-distinct-phenotype","Postpartum breast cancer: evidence for a distinct phenotype","","The study investigates early-onset breast cancer trends alongside delayed childbearing, proposing a distinct postpartum breast cancer (PPBC) subtype defined by time since last birth (TSLB) and biomarker expression. GeoMx Digital Spatial Profiling measures associations between TSLB and 71 proteins in breast tumors from young women. Results link PR and PTEN to longer TSLB in multiple segments, reveal additional subtype- and compartment-dependent associations, and connect RNA profiles to T-cell exhaustion in TCGA. Findings support PPBC as a coherent biological phenotype with prevention and therapy implications.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/postpartum-breast-cancer-evidence-for-a-distinct-phenotype/354128/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/postpartum-breast-cancer-evidence-for-a-distinct-phenotype/354128.png","ImageObject",300,407,{"name":42,"@type":43},"Putri","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What defines the proposed postpartum breast cancer (PPBC) phenotype?","Question",{"text":63,"@type":64},"The study defines PPBC as a biologically coherent subtype characterized by time since last birth (TSLB) and a specific biomarker expression profile.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the relationship between TSLB and biomarkers analyzed?",{"text":68,"@type":64},"GeoMx Digital Spatial Profiling measured associations between TSLB and 71 proteins, followed by univariable linear regression and multivariable sliced inverse regression to handle higher-order biomarker interactions.",{"name":70,"@type":61,"acceptedAnswer":71},"Which biomarkers showed associations with longer TSLB and did results hold across validations?",{"text":72,"@type":64},"Keratin-rich segments showed PR and PTEN associated with longer TSLB, and additional markers varied by segment. OPAL multiplex immunofluorescence assays replicated several DSP findings, particularly with subtype stratification and compartment matching, and TCGA supported related immune signaling patterns.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},354128,1791126038,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962085571259,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","JNCI: Journal of the National Cancer Institute, 2026, 118(5), 926–935  \n[https://doi.org/10.1093/jnci/djag003](https://doi.org/10.1093/jnci/djag003)  \nAdvance Access Publication Date: January 9, 2026  \nArticle  \nPostpartum breast cancer: evidence for a distinct phenotype  \nMark E. Sherman , MD􀀃 ,1, Lola Etievant , PhD2, Robert A. Vierkant, MS3, Stacey J. Winham , PhD3, Kathryn J. Ruddy , MD4, Laura Pacheco-Spann , DHSc1, Daniel P. Wickland , PhD1, Nicole Cruz-Reyes , BS5, Melody Stallings-Mann , PhD5, Derek Radisky , PhD5, E. Aubrey Thompson , PhD5, Jennifer M. Kachergus, BS5, Ji Shi , PhD5, Shoshana M. Rosenberg, ScD6, 7, Craig Snow , MHA6, 7, Gregory J. Kirkner , MPH6, 7, Lidia Schapira, MD8, Jeffrey M. Peppercorn , MD9, Steven Come , MD10, Virginia F. Borges , MD11, Ellen Warner, MD12, Laura C. Collins, MD13, Ann H. Partridge , MD6, 7, Ruth M. Pfeiffer , PhD2 1Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, United States  \n2Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States  \n3Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States 4Department of Oncology, Mayo Clinic, Rochester, MN, United States 5Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, United States 6Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States  \n7Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, United States  \n8Department of Medicine, Division of Medical Oncology, Stanford University, Stanford, CA, United States 9Department of Medicine, Division of Medical Oncology, Massachusetts General Hospital, Boston, MA, United States 10Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, United States  \n11Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States  \n12Department of Medicine, Division of Medical Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada 13Pathology, Beth Israel Deaconess Medical Center, Boston, MA, United States  \n􀀃 Corresponding author: Mark E. Sherman, MD, Quantitative Health Sciences, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, United States ([sherman.mark@mayo.edu](sherman.mark@mayo.edu)) .  \nPresent address: Shoshana M. Rosenberg, Population Health Sciences, Weill Cornell Medicine, New York, NY, United States.  \nPresent address: Laura C. Collins, Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, United States.  \nAuthor Contributions: M.E. Sherman, L. Etievant, A.H. Partridge, and R.M. Pfeiffer contributed equally to this work.  \nAbstract  \nBackground: The incidence of early onset breast cancers (BCs) has increased, paralleling rising trends in delayed childbearing. We hypothesize that a distinct postpartum BC (PPBC) subtype, identifiable by time since last birth (TSLB) and biomarker expression, contributes to this trend.  \nMethods: We applied GeoMx Digital Spatial Profiling (DSP) to measure associations between TSLB and 71 proteins in 640 BCs from women aged ≤40 years included in the Young Women’s Breast Cancer Study. We analyzed data using univariable linear regression and multivariable sliced inverse regression to account for higher order interactions among biomarkers.  \nResults: In keratin-rich segments, progesterone receptor (PR) (P ¼ 1.00 × 10−4) and PTEN (P ¼ 1.00 × 10−3) were associated with longer TSLB; multivariable analyses revealed positive associations for GZMB (P ¼4.00 × 10−4), SMA (P ¼ 1.00 × 10−4), and NF-1 (P ¼ 1.00 × 10−3) . In keratin-poor segments, univariable significant positive associations were found for PR (P ¼ 2.00 × 10−4) and PTEN (P ¼ 1.00 × 10−3), whereas CD20 (P ¼ 3.00 × 10−4) and CTLA4 (P ¼4.00 × 10−5) were negatively associated; multivariable significant associations were found for fibronectin (P ¼ 3.00 × 10−5) and pan-Akt (P ¼ 1.00 × 10−3) . Associations persisted after adjustment for multiple comparisonsand B","cbCairxpbWZa6gNy","https://ap.wps.com/l/cbCairxpbWZa6gNy","pdf",1195983,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Breast cancer incidence and clinical phenotypes\n## Rationale for postpartum subtype","[{\"question\":\"What defines the proposed postpartum breast cancer (PPBC) phenotype?\",\"answer\":\"The study defines PPBC as a biologically coherent subtype characterized by time since last birth (TSLB) and a specific biomarker expression profile.\"},{\"question\":\"How was the relationship between TSLB and biomarkers analyzed?\",\"answer\":\"GeoMx Digital Spatial Profiling measured associations between TSLB and 71 proteins, followed by univariable linear regression and multivariable sliced inverse regression to handle higher-order biomarker interactions.\"},{\"question\":\"Which biomarkers showed associations with longer TSLB and did results hold across validations?\",\"answer\":\"Keratin-rich segments showed PR and PTEN associated with longer TSLB, and additional markers varied by segment. OPAL multiplex immunofluorescence assays replicated several DSP findings, particularly with subtype stratification and compartment matching, and TCGA supported related immune signaling patterns.\"}]","Postpartum breast cancer: evidence for a distinct phenotype | PDF",1790109141,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e9e503e3b6f0571fe9bf3adfbf3fcca6.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/58b94befa25a1b220738c4522ce98c02.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a097b18bd766d79f4612c907353eed96.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d0e339186e6aef2d47cbd05a7b701ca8.webp",980,1287]